期刊文献+

洛莫司汀脂质体包封率的测定 被引量:7

Determination of entrapment efficiency of lomustine liposomes
原文传递
导出
摘要 目的对洛莫司汀脂质体进行质量评价,建立洛奠司汀脂质体包封率的测定方法。方法采用微柱离心法分离洛莫司汀脂质体与游离药物,采用HPLC法测定洛莫司汀含量。结果微柱离心法对洛莫司汀游离药的吸附率在97.25%~98.36%内,空白脂质体回收率在98.60%-100.5%内,洛莫司汀脂质体和游离洛莫司汀得到良好的分离;在选定色谱条件下,洛莫司汀与脂质体分离良好,辅料不干扰测定,洛莫司汀质量浓度在0.5—50.0mg·L^-1内与峰面积呈良好的线性关系(r=0.9999),日内和日间RSD均小于2%(n=5),加样回收率在97.96%-98.79%内。结论微柱离心-HPLC法可用于洛莫司汀脂质体包封率的测定。 Objective To evaluate the quality and determine the entrapment efficiency of lomustine lipo- somes. Methods The microcolumn centrifuge method was adopted to separate the free lomustine from lipo- some and HPLC method was used for analyzing the amount of lomustine. Results The interception to free lomustine by microcolumn centrifuge method was 97.25% -98.36%, the recovery rate of liposomes was 98. 60% - 100. 5% ,lomustine liposomes and lomustine could be well separated;A calibrated linear curve of lomustine was within 5.0 - 50. 0 mg.L^-1 ( r = 0. 999 9 ), and RSDs within day and between days were all less than 2% ( n = 5 ), the recovery rate of lomustine with blank liposomes was in a range of 97.96% - 98.79%. Conclusions The microcolunm centrifuge-HPLC method can be used for the determination of entrapment efficiency of lomustine liposomes.
出处 《沈阳药科大学学报》 CAS CSCD 北大核心 2009年第6期447-450,共4页 Journal of Shenyang Pharmaceutical University
基金 国家自然科学基金资助项目(30672555)
关键词 洛莫司汀 脂质体 高效液相色谱法 微柱离心法 包封率 lomustine liposome HPLC microcolumn centrifugation entrapment efficiency
  • 相关文献

参考文献9

  • 1CARTER S K,SCHABEL F M,BRODER L E,et al.1,3-Bis(2-chloroethyl)-1-nitrosourea(bcnu)and other nitrosoureas in cancer treatment:a review[J].Advanced Cancer Research,1972,16:273-332.
  • 2KIVELA T,SUCIU S,HANSSON J,et.al.Bleomycin,vincristine,lomustine and dacarbazine(BOLD)in combination with recombinant interferon alpha-2b for metastatic uveal melanoma[J].European Journal of Cancer,2003,39:1115-1120.
  • 3方伟,阚庆生,王新民,许爱荣.替尼泊苷和洛莫司汀联合治疗18例转移性脑肿瘤[J].河南实用神经疾病杂志,2001,4(2):51-52. 被引量:1
  • 4NAGAHIRO S,YAMAMOTO Y,DIKSIC M,et al.Neurotoxicity after intracarotid nitrosourea administration:hemodynamic changes studied by double-tracer autoradiography[J].Neurosurgery(Baltimore),1991,29:19-26.
  • 5GABIZON A,CATANE R,UZIELY B.Prolonged circulation time and enhanced accumulation in malignant exudates of doxorubicin encapsulated in polyethyleneglycol coated liposomes[J].Cancer Research,1994,54:987-992.
  • 6姜殿君,王俊平,赵丽妮.抗癌药物脂质体及其研究进展[J].中国现代医药杂志,2007,9(4):152-154. 被引量:18
  • 7田新华,江澄川,张其清,任磊,刘玲蓉.一种微量CCNU测定方法的建立和评价[J].临床神经科学,1996,4(4):208-211. 被引量:1
  • 8沈圆圆,邱利焱,金一.高效液相色谱法测定洛莫司汀脂质体药物含量及包封率[J].药物分析杂志,2005,25(3):317-319. 被引量:6
  • 9BETHUNE C,BLUMA,GEYER J R,et al.Lipid association increases the potency against primary medulloblastoma cells and systemic exposure of 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea(CCNU)in rats[J].Pharmaceutical Rserarch,1999,16(6):896-903.

二级参考文献20

  • 1邹金华,刘国龙,盛信秀,郑航,陈碧君.VM-26与CCNU联合治疗肺癌脑转移[J].中国肿瘤临床,1997,24(3):224-225. 被引量:5
  • 2[1]Vaage J,Mayhew E,Lasic D.Therapy of primary and metastatic mouse mammary carcinomas with doxorubicin encapsulated in long circulating liposomes[J].Int J Cancer,1992,51(6):942-948
  • 3[2]Russo D,Piccaluga PP,Michieli M.Liposomal daunorubicin (DaunoXome) for treatment of poor-risk acute leukemia.Ann Hematol,2002,81 (8):462-466
  • 4[4]Overmoyer B,Silverman P,Holder LW.Pegylated liposomal Doxorubicin and cyclophosphamide as first-line therapy for patients with metastatic or recurrent breast cancer.Clin Breast Cancer,2005,6 (2):150-157
  • 5[5]Krown SE,Northfelt DW,Osoba D.Use of liposomal anthracyclines in Kaposi's sarcoma.Semin Oncol,2004,31(6 Suppl 13):36-52
  • 6[6]Mross K,Niemann B,Massing U.Pharmacokinetics of liposomal doxorubicin (TLC-D99; Myocet) in patients with solid tumors:an open-label,single-dose study.Cancer Chemother Pharmacol,2004,54(6):514-24
  • 7[7]Janssen AP,Schiffelers RM,ten Hagen TL.Peptide-tsrgeted PEG-liposomes in anti-angiogenic therapy.Int J Pharm,2003,254(1):55-58
  • 8[8]Schiffelers RM,Koning GA,ten Hagen TL.Anti-tumor efficacy of tumor vasculature-targeted liposomal doxorubicin.J Control Release,2003,91 (1-2):115-122
  • 9[9]Koning GA,Fretz MM,Woroniecka U.Targeting liposomes to tumor endothelial cells for neutron capture therapy.Appl Radiat Isot,2004,61 (5):963-967
  • 10[10]Dubey PK,Mishra V,Jain S.Liposomes modified with cyclic RGD peptide for tumor targeting.J Drug Target,2004,12(5):257-64

共引文献22

同被引文献2008

引证文献7

二级引证文献49

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部